Latest Sanfilippo Syndrome Stories
CALABASAS, Calif., April 8, 2015 /PRNewswire/ -- ArmaGen, Inc., a privately held biotechnology company focused on developing novel therapies to treat severe neurological disorders, announced
SAN DIEGO, March 10, 2015 /PRNewswire/ -- ArmaGen Technologies (Calabasas, CA), a privately held biotechnology company focused on developing revolutionary therapies to treat severe neurological
LEXINGTON, Mass., Feb.
LEXINGTON, Mass., Jan.
LEXINGTON, Mass., Dec.
CALABASAS, Calif., Dec.
ArmaGen to Receive up to Approximately $225 Million Including Initial Upfront Payment of $15 Million in Cash and Equity, an Additional Equity Investment, R&D Funding, Development and Sales Milestones,
LEXINGTON, Mass., June 3, 2014 /PRNewswire/ -- Synageva BioPharma Corp. (Synageva) (NASDAQ: GEVA), a biopharmaceutical company
ORLANDO, Fla., June 2, 2014 /PRNewswire/ -- There is a rock anthem titled "School's Out for Summer".
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.